These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9471158)

  • 21. [Development of in situ TRAP assay detecting telomerase activity in cell].
    Ohyashiki K; Yahata N; Ohyashiki JH
    Nihon Rinsho; 1998 May; 56(5):1159-64. PubMed ID: 9613114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance.
    Gümüş-Akay G; Unal AE; Bayar S; Karadayi K; Elhan AH; Sunguroĝlu A; Tükün A
    Genet Mol Res; 2007 Feb; 6(1):41-9. PubMed ID: 17469053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay.
    Takaishi H; Kitamoto M; Takahashi S; Aikata H; Kawakami Y; Nakanishi T; Nakamura Y; Shimamoto F; Kajiyama G; Ide T
    Cancer; 2000 Jan; 88(2):312-7. PubMed ID: 10640962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase activity in neuroendocrine tumors.
    Bockhorn M; Frilling A; Clauer U; Hertl M; Broelsch CE
    Int J Surg Investig; 2000; 2(3):219-25. PubMed ID: 12678522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
    Kawai J; Kodera Y; Fujiwara M; Kasai Y; Nagasaka T; Koike M; Hibi K; Ito K; Akiyama S; Nakao A
    Hepatogastroenterology; 2005; 52(63):959-64. PubMed ID: 15966241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of telomerase activity in bronchoscopic brush-off samples in patients with lung cancer].
    Yan YL; Zheng JX; Wang X; Wang Y; Yang JY
    Ai Zheng; 2002 Jul; 21(7):768-71. PubMed ID: 12479104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility of telomerase in cancer.
    Hiyama E; Hiyama K
    Oncogene; 2002 Jan; 21(4):643-9. PubMed ID: 11850791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomerase activity in esophageal squamous cell carcinoma and lesions unstained with Lugol's solution.
    Yoneyama K; Yasumoto S; Aoyama N; Koizumi H; Imada T; Takanashi Y
    Hepatogastroenterology; 2005; 52(66):1734-7. PubMed ID: 16334768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput analysis of telomerase by capillary electrophoresis.
    Atha DH; Miller K; Sanow AD; Xu J; Hess JL; Wu OC; Wang W; Srivastava S; Highsmith WE
    Electrophoresis; 2003 Jan; 24(1-2):109-14. PubMed ID: 12652580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomerase activity in benign and malignant cytologic fluids.
    Mu XC; Brien TP; Ross JS; Lowry CV; McKenna BJ
    Cancer; 1999 Apr; 87(2):93-9. PubMed ID: 10227600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microarray TRAP--a high-throughput assay to quantitate telomerase activity.
    Heller-Uszynska K; Kilian A
    Biochem Biophys Res Commun; 2004 Oct; 323(2):465-72. PubMed ID: 15369774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-time telomeric repeat amplification protocol using the duplex scorpion and two reverse primers system: the high sensitive and accurate method for quantification of telomerase activity.
    Huang YP; Liu ZS; Tang H; Liu M; Li X
    Clin Chim Acta; 2006 Oct; 372(1-2):112-9. PubMed ID: 16714009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications.
    Matthews P; Jones CJ; Skinner J; Haughton M; de Micco C; Wynford-Thomas D
    J Pathol; 2001 Jun; 194(2):183-93. PubMed ID: 11400147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sensitive direct human telomerase activity assay.
    Cohen SB; Reddel RR
    Nat Methods; 2008 Apr; 5(4):355-60. PubMed ID: 18376394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of telomerase activity in prostate needle-biopsy samples].
    Wang X; Zhang Y; Ding Q; Ye L; Zhai L; Jia W
    Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):762-4. PubMed ID: 11829949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples.
    Hiyama E; Saeki T; Hiyama K; Takashima S; Shay JW; Matsuura Y; Yokoyama T
    Cancer; 2000 Aug; 90(4):235-8. PubMed ID: 10966564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase activity and telomere detection during early bovine development.
    Betts DH; King WA
    Dev Genet; 1999; 25(4):397-403. PubMed ID: 10570471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of human telomerase activity by telomerase TRAP-ELISA assay].
    Wei L; Guo Y; Yan Z
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):264-6. PubMed ID: 10920979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
    Simícková M; Nekulová M; Pecen L; Cernoch M; Vagundová M; Pacovský Z
    Neoplasma; 2001; 48(4):267-73. PubMed ID: 11712677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.